Skip to main content
Clinical Trials/NCT02864537
NCT02864537CompletedNot Applicable

Comparison Between Conventional Anticoagulation Treatment and Self-management of Anticoagulation Treatment

University of Bergen0 sites130 target enrollmentStarted: January 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
130
Primary Endpoint
Change in Time in therapeutic range (TTR)

Study Overview

Brief Summary

The aim of the study was to compare self-management of anticoagulant treatment with conventional anticoagulant treatment in Norway.

Detailed Description

Patients (n=132) on anticoagulant treatment with warfarin participated in a 21 weeks training program where they learned how to analyse International Normalised Ratio (INR) using the point-of-care instrument CoaguChek®XS and dose warfarin. The patients had to display their skills through a test before considered self-managing. They continued to measure INR weekly for two years. All INR values during the training program and self-control period were collected. In addition, the patients were told to notify if they had any complications during this period. INR values and complications two years before enrolment was collected from INR cards and/or their general practioner. The participant filled in a quality of life-questioner at enrolment and after two years of self-management.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •On life-long oral anticoagulation therapy
  • •Judged to be qualified for patient self-management anticoagulation treatment by their GP
  • •Motivated to follow the training program

Exclusion Criteria

  • •Drug abuse
  • •Liver disease

Arms & Interventions

Conventional treatment

No Intervention

Conventional anticoagulation treatment Before enrolment

Self-management

Experimental

Trained to monitor INR and dose warfarin

Intervention: Training (Other)

Outcomes

Primary Outcomes

Change in Time in therapeutic range (TTR)

Time Frame: From two years before enrolment until two years of self management

Change in TTR from conventional treatment to self-management

Secondary Outcomes

  • Change in number of complications(From two years before enrolment until two years of self management)
  • Quality of life (QoL)(Baseline before training and after two years with self-management)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Una Ørvim Sølvik

Associate Professor

University of Bergen

Similar Trials